Sonal Singh to Drug-Related Side Effects and Adverse Reactions
This is a "connection" page, showing publications Sonal Singh has written about Drug-Related Side Effects and Adverse Reactions.
Connection Strength
2.348
-
Singh S, Cocoros NM, Li X, Mazor KM, Antonelli MT, Parlett L, Paullin M, Harkins TP, Zhou Y, Rochon PA, Platt R, Dashevsky I, Massino C, Saphirak C, Crawford SL, Gurwitz JH. Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial. PLoS One. 2024; 19(2):e0297562.
Score: 0.789
-
Pradhan R, Singh S. Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis. Drug Saf. 2018 Sep; 41(9):849-857.
Score: 0.541
-
Iyer G, Marimuthu SP, Segal JB, Singh S. An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System. Drug Saf. 2017 09; 40(9):799-808.
Score: 0.505
-
Singh S, Loke YK. Drug safety assessment in clinical trials: methodological challenges and opportunities. Trials. 2012 Aug 20; 13:138.
Score: 0.356
-
Loke YK, Ho R, Smith M, Wong O, Sandhu M, Sage W, Singh S. Systematic review evaluating cardiovascular events of the 5-alpha reductase inhibitor - Dutasteride. J Clin Pharm Ther. 2013 Oct; 38(5):405-15.
Score: 0.095
-
Singh S, Nautiyal A. Secondary hypertension due to drugs and toxins--a challenge for research on harm. South Med J. 2007 Jul; 100(7):665-6.
Score: 0.062